Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New monitor may spot breathing trouble in COPD patients during routine procedures

NCT ID NCT07262905

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study observed 100 people with COPD who were sedated for a stomach and colon exam. Researchers wanted to see if certain risk factors, like symptom severity or past hospital stays, could predict breathing problems during the procedure. They also tested a new monitor called the Integrated Pulmonary Index (IPI) to see if it could spot trouble earlier than standard monitors. The study did not test any new treatments, only observed what happened during routine care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

100 people

The number who actually took part.

Started

Jan 2025

Finished

Jul 2025

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Adult patients (≥18 years) with confirmed COPD undergoing elective gastrointestinal endoscopic procedures under sedation analgesia at a tertiary training and research hospital.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria:Age ≥ 18 years Diagnosed with Chronic Obstructive Pulmonary Disease (COPD) according to GOLD 2024 criteria Classified as ASA physical status I-IV Undergoing elective gastrointestinal endoscopic procedure under sedation analgesia Suitable for sedation outside the operating room Provided written informed consent - Exclusion Criteria: Age \< 18 years Unstable cardiovascular or respiratory condition Requirement for general anesthesia or advanced airway management Pregnancy Known hypersensitivity to sedative medications Refusal or inability to provide informed consent \-

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COPD (chronic obstructive pulmonary disease) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Bursa Yüksek İhtisas Training and Research Hospital

    Bursa, Marmara Region, 16310, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.